Team: Bios
Ashley Dombkowski, PhD
Managing Director
Dr. Ashley Dombkowski joined MPM Capital in 2000. Before joining MPM, she was a public market investor and Healthcare Equity Analyst covering biotech, medical device, and pharmaceutical stocks for Tiger Management, L.L.C., a diversified hedge fund. Prior to Tiger, Dr. Dombkowski followed the all-cap universe of public medical technology stocks as an Equity Research Associate at Dresdner RCM Global Investors. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and a B.A. cum laude and with Departmental Honors from Wellesley College.
Present Boards
EpiZyme, Inc.
Neosil, Inc.
Nevro, Inc. (Observer)
Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) (Observer)
Past Boards
BioVitrum AB (Stockholm:BVT.ST) (Observer)
Enteromedics, Inc. (NASDAQ:ETRM)
Hemosense, Inc.
LXN Corporation
Peptimmune, Inc.
Portola Pharmaceuticals, Inc.
Restore Medical, Inc. (NASDAQ:REST)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Tercica, Inc. (NASDAQ:TRCA)